Atom Investors LP Bristol Myers Squibb CO Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $1.48 Million - $1.95 Million	36,849 Added 663.83%	42,400 $1.76 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $881,392 - $999,328	-18,370 Reduced 76.79%	5,551 $301,000
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $1.16 Million - $1.38 Million	23,921 New	23,921 $1.23 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $309,547 - $343,019	5,390 New	5,390 $325,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.